Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1157075 · PMCB

PharmaCyte Biotech, Inc.

Filing with the SEC SEC-reporting company Las Vegas, NV Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Dec 5, 2025 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Change of auditorOn Oct 16, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
  • Net loss in 2025Net loss of $19.4M for the year (2024: $30.7M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$0$0
Net income (loss)−$19.4M$30.7M
Total assets$55.9M$43.8M
Total liabilities$16.5M$3.6M
Stockholders’ equity$38.1M$40.3M
Cash and equivalents$20.2M$16.4M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends April 30. Check the annual report for the exact figures and periods.

Name as filed
PharmaCyte Biotech, Inc.
Formerly: Nuvilex, Inc.
CIK
0001157075
Tickers
PMCB
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Nevada
Business address
Las Vegas, Nevada
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
April 30
Last annual report
10-K for the period ended Apr 30, 2026
Last quarterly report
10-Q for the quarter ended Jul 31, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 16, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Oct 16, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jul 31, 2026
    Form 10-Q · filed Sep 14, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Apr 30, 2026
    Form 10-K · filed Jul 29, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Apr 2, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2026
    Form 10-Q · filed Mar 17, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Oct 31, 2025
    Form 10-Q · filed Dec 18, 2025 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Dec 15, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Dec 5, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Oct 31, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jul 31, 2025
    Form 10-Q · filed Sep 15, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 7.01, 9.01 · filed Sep 5, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Sep 4, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Apr 30, 2025
    Form 10-K · filed Aug 11, 2025 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Jul 29, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2025
    Form 10-Q · filed Mar 17, 2025 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Feb 26, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Oct 31, 2024
    Form 10-Q · filed Dec 13, 2024 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Sep 17, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jul 31, 2024
    Form 10-Q · filed Sep 17, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Apr 30, 2024
    Form 10-K · filed Aug 13, 2024 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Jul 29, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed May 30, 2024 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 8.01, 9.01 · filed May 23, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2024
    Form 10-Q · filed Mar 18, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Oct 31, 2023
    Form 10-Q · filed Dec 15, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 24, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Nov 22, 2023 · filing
  • Change of auditor
    Form 8-K · items 4.01 · filed Nov 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jul 31, 2023
    Form 10-Q · filed Sep 18, 2023 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Sep 15, 2023 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Aug 4, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Apr 30, 2023
    Form 10-K · filed Jul 31, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jan 31, 2023
    Form 10-Q · filed Mar 16, 2023 · filing